Swiss pharma giant Roche could be among the best-placed drugmakers to tackle two of today’s biggest challenges in global ...

Boston, USA-based Modulight Biotherapeutics, a developer of novel optogenetic platform for the treatment of neurological ...

Escalating US tariff and pricing reforms are pushing pharmaceutical companies to localize manufacturing and rethink their ...

Chinese biotech DeliNova Therapeutics has completed its seed and angel funding rounds, raising 60 million yuan ($8.3 million) ...

US biotech Lyell Immunopharma (Nasdaq: LYEL) has broadened its cell therapy portfolio by acquiring global rights to LYL273, a ...

Peru is emerging as one of Latin America’s most proactive countries in strengthening its regulatory system for ...

The antibody-mediated rejection (AMR) market is set for solid expansion through 2034, driven by rising transplant volumes, ...

The US Department of Health and Human Services (HHS) and the Food and Drug Administration (FDA) today announced that Dr ...

LB Pharmaceuticals, a clinical-stage biopharmaceutical company developing novel therapies for schizophrenia, bipolar ...

Swiss-founded data-driven medicine software company Sophia Genetics has announced two collaborations to connect its ...

Shares in Germany’s Bayer looked set to close 6% higher Wednesday, following the company’s presentation of its quarterly ...

US biotech Neurocrine Biosciences (Nasdaq: NBIX) said its Phase II trial of NBI-1070770 in adults with major depressive ...